Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 29, Issue 4, 2005, Pages 378-382

  Eugster, Thomas ^a,c   Huber, A ^b   Obeid, T ^a   Schwegler, I ^a   Gurke L ^a   Stierli, P ^a  

^a University Centre Aarau Basel   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Abdominal aortic aneurysm; Metalloproteinases; Serum marker

Indexed keywords

GELATINASE A; GELATINASE B; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; AGED; ARTERY DIAMETER; ARTERY DILATATION; ARTERY WALL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

EID: 14844284613     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2004.12.007     Document Type: Article

References (34)

1. R.F. Gillium Epidemiology of aortic aneurysm in the United States J Clin Epidemiol 48 1995 1289-1298
2. H. Bengtsson D. Bergqvist Ruptured abdominal aortic aneurysms: A population-based study J Vasc Surg 18 1993 74-80
3. J. Collin L. Araujo J. Walton D. Lindsell Oxford screening program for abdominal aortic aneurysm in men aged 65 to 74 years Lancet 2 1988 613-615
4. R.A. Scott N.M. Wilson H.A. Ashton D.N. Kay Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study Br J Surg 82 1995 1066-1070
5. K.A. Vardulaki T.C. Prevost N.M. Walker N.E. Day A.B. Wilmink C.R. Quicket al. Incidence among men of asymptomatic aortic aneurysms: estimates from 500 screen detected cases J Med Screen 6 1999 50-54
6. F.A. Lederle G.R. Johnson S.E. Wilson E.P. Chute R.S. Hye M.S. Makaroun et al. Aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators Arch Intern Med 160 2000 1425-1430
7. B.P. Heather K.R. Poskitt J.J. Earnshaw M. Whyman E. Shaw Population screening reduces mortality rate from aortic aneurysm in men Br J Surg 87 2000 750-753
8. J.S. Lindholt S. Juul H. Fasting E.W. Henneberg Hospital cost and benefits of screening for abdominal aortic aneurysms. Results from a randomized population screening trial Eur J Vasc Surg 23 2002 55-60
9. R.D. Thompson Detection and management of small aortic aneurysms NEJM 346 2002 1437-1444
10. J. Satta T. Juvonen K. Haukipuro M. Juvonen M.I. Kairaluoma Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples J Vasc Surg 22 1995 155-160
11. M.I. Patel J. Melrose P. Ghosh M. Appleberg Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms J Vasc Surg 24 1996 82-92
12. K.M. Newman Y. Ogata A.M. Malon E. Irizarry R.H. Gandhi H. Nagase et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm Arterioscler Thromb 14 1994 1315-1320
13. P.K. Shah Inflammation, metalloproteinases, and increased proteolysis Circulation 96 1997 2115-2117
14. J. Satta K. Haukipuro M.I. Kairaluoma T. Juvonen Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms J Vasc Surg 25 1997 909-915
15. D.M. Hovsepian S.J. Ziborin M.K. Sakurai J.K. Lee J.A. Curci R.W. Thompson Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: A circulating marker of degenerative aneurysm disease JVIR 11 2000 1345-1352
16. R.W. Busuttil A.M. Abou-Zamzam H.I. Machleder Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms Arch Surg 115 1980 1373-1378
17. P.B. Dobrin W.H. Baker W.C. Gley Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms Arch Surg 119 1984 405-409
18. A. Wills M.M. Thompson M. Crowther R.D. Sayers P.R. Bell Pathogenesis of abdominal aortic aneurysms-cellular and biochemical mechanisms Eur J Vasc Endovasc Surg 12 1996 391-400
19. R.W. Thompson D.R. Holmes R.A. Mertens S. Liao M.D. Botney R.P. Mecham et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages J Clin Invest 96 1995 318-326
20. V. Davis R. Persidskaia L. Baca-Regen Y. Hoh H. Nagase Y. Persidsky et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 18 1998 1625-1633
21. N. Tamarina W.D. McMillan M.S. Shively W.H. Pearce Expression of matrix metalloproteinases and their inhibitors in aneurysmal and normal aorta Surgery 122 1997 264-272
22. J.B. Knox G.K. Sukhova A.D. Whittermore P. Libby Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic disease Circulation 95 1997 205-212
23. J.S. Lindholt S. Vammen H. Fasting E.W. Henneberg L. Heikendorff The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study Eur J Vasc Endovasc Surg 20 2000 281-285
24. J.S. Lindholt L. Heickendorff S. Vammen H. Fasting E.W. Henneberg Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms Eur J Vasc Endovasc Surg 21 2001 235-240
25. N. Vine J.T. Powell Metalloproteinases in degenerative aortic disease Clin Sci (Colch) 81 1991 233-239
26. R.D. Kenagy A.W. Clowes A possible role for MMP-2 and MMP-9 in the migration of primate arterial smooth muscle cells through native matrix Ann N Y Acad Sci 732 1994 462-465
27. M. Crowther N.P. Brindle R. Sayers P.R. Bell M.M. Thompson Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vivo Ann N Y Acad Sci 800 1996 283-285
28. M.I. Patel J. Melrose P. Ghosh M. Appleberg Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms J Vasc Surg 24 1996 82-92
29. N. Sakalihasan P. Delvenne B.V. Nusgens R. Limet C.M. Lapierre Activated forms of MMP-2 and MMP-9 in abdominal aortic aneurysms J Vasc Surg 24 1996 127-133
30. W.D. McMillan N.A. Tamarina M. Cipollone D.A. Johnson M.A. Parker W.H. Pearce Size matters. The relationship between MMP-9 expression and aortic diameter Circulation 96 1997 2228-2232
31. T. Freestone R.J. Turner A. Coady D.J. Higman R.M. Greenhalgh J.T. Powell Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 1995 1145-1151
32. W.D. McMillan W.H. Pearce Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms J Vasc Surg 29 1999 122-129
33. G. Sangiorgio R. D'Averio A. Mauriello M. Bondio M. Pontillo S. et al. Castelvecchio Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic exclusion after endovascular treatment Circulation 104 Suppl I 2001 I-288-I-295
34. D.R. Lorelli J.M. Jean-Claude C.J. Fox J. Clyme R.A. Cambria G.R. Seabrook et al. Response of plasma matrix metalloproteinase-9 to conventional exclusion: Implications for endoleak J Vasc Surg 35 2002 916-922